
Sr. Manager, Marketing
Alnylam Pharmaceuticals
USA (Hybrid)

Brand
Help build salary transparency at Alnylam Pharmaceuticals
Share your compensation anonymously to see full data.




Open marketing jobs over time
Company growth over the last 12 months
Total funding
$4.5B
Last raise
$661.3M
Post IPO Debt, 6 months ago
Funding history
Sep 2025
Post IPO Debt Alnylam Pharmaceuticals · $661.3M
Sep 2022
Post IPO Debt Alnylam Pharmaceuticals · $900M
Apr 2020
Post IPO Debt Alnylam Pharmaceuticals · $750M
Apr 2020
Post IPO Equity Alnylam Pharmaceuticals · $250M
Apr 2019
Post IPO Equity Alnylam Pharmaceuticals · $800M
Jan 2015
Post IPO Equity Alnylam Pharmaceuticals · $450M
LinkedIn followers
Follower count and growth
Total followers
272.8K
12-mo growth
+22.6%
Monthly growth
+1.9%

Alnylam Pharmaceuticals
USA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (On-site)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
USA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)

Alnylam Pharmaceuticals
Cambridge, MA (On-site)

Alnylam Pharmaceuticals
Cambridge, MA (Hybrid)